J. M. LAZARUS, M.D.; C. L. HAMPERS, M.D.
The major conclusion one must draw from The Ninth Report of the Human Renal Transplant Registry (1) is that since 1966 there has been no significant improvement in patient survival or duration of graft function in renal transplantation. This plateau has occurred despite the use of more sophisticated tissue typing, antilymphocyte globulin, thoracic duct lymphocyte depletion, and a considerable surgical experience. The impressive gains scored before 1966 were clearly due to the introduction of azathioprine and corticoids, the mainstay of present immunosuppressive therapy. Several important factors that affect renal transplant statistics may be influenced by the referring physician, who is
Learn more about subscription options.
Register Now for a free account.
LAZARUS JM, HAMPERS CL. Renal Transplantation—1972. Ann Intern Med. 1972;76:504–505. doi: 10.7326/0003-4819-76-3-504
Download citation file:
Published: Ann Intern Med. 1972;76(3):504-505.
Nephrology, Renal Replacement Therapy.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only